Sheron Latcha

893 total citations
31 papers, 556 citations indexed

About

Sheron Latcha is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sheron Latcha has authored 31 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Sheron Latcha's work include Chemotherapy-induced organ toxicity mitigation (8 papers), Dialysis and Renal Disease Management (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Sheron Latcha is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (8 papers), Dialysis and Renal Disease Management (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Sheron Latcha collaborates with scholars based in United States, Canada and Belgium. Sheron Latcha's co-authors include Carlos D. Flombaum, Edgar A. Jaimes, Swati Mehta, Sujata Patil, Ilya Glezerman, William C. Huang, Jeremy C. Durack, Inderbir S. Gill, David L. Graham and Robert G. Uzzo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Cancer.

In The Last Decade

Sheron Latcha

25 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheron Latcha United States 9 307 218 164 111 98 31 556
Fulya Öz Puyan Türkiye 14 109 0.4× 158 0.7× 90 0.5× 29 0.3× 128 1.3× 70 567
Kouju Kamata Japan 16 110 0.4× 107 0.5× 73 0.4× 275 2.5× 81 0.8× 65 559
Keith E. Eidman United States 7 269 0.9× 195 0.9× 28 0.2× 130 1.2× 124 1.3× 9 511
Nathan Susnik Germany 12 64 0.2× 143 0.7× 40 0.2× 161 1.5× 74 0.8× 13 469
Qing Jiang China 11 232 0.8× 73 0.3× 18 0.1× 45 0.4× 153 1.6× 44 555
Snehal G. Thakkar United States 9 207 0.7× 128 0.6× 69 0.4× 38 0.3× 39 0.4× 18 427
Wenyu Zou China 10 106 0.3× 179 0.8× 62 0.4× 250 2.3× 31 0.3× 24 561
Jingyuan Wang China 10 98 0.3× 197 0.9× 40 0.2× 20 0.2× 63 0.6× 36 626
Yi Shao China 13 413 1.3× 133 0.6× 14 0.1× 42 0.4× 52 0.5× 39 630
Taro Kubo Japan 10 104 0.3× 85 0.4× 23 0.1× 58 0.5× 86 0.9× 56 369

Countries citing papers authored by Sheron Latcha

Since Specialization
Citations

This map shows the geographic impact of Sheron Latcha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheron Latcha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheron Latcha more than expected).

Fields of papers citing papers by Sheron Latcha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheron Latcha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheron Latcha. The network helps show where Sheron Latcha may publish in the future.

Co-authorship network of co-authors of Sheron Latcha

This figure shows the co-authorship network connecting the top 25 collaborators of Sheron Latcha. A scholar is included among the top collaborators of Sheron Latcha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheron Latcha. Sheron Latcha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashidi, Arash, et al.. (2025). Electrolytes Abnormalities in Cancer Patients. American Journal of Nephrology. 1–20. 1 indexed citations
2.
Latcha, Sheron, et al.. (2025). Onconephrology. PubMed. 32(1). 69–78.
3.
Latcha, Sheron, et al.. (2024). Kidney Disease in Systemic Amyloidosis. Kidney360. 5(12). 1925–1937. 2 indexed citations
4.
Latcha, Sheron, et al.. (2024). Renal Salt Wasting Following Cisplatin. Kidney360. 5(4). 604–606.
5.
Latcha, Sheron, Mohit Gupta, I‐Hsin Lin, & Edgar A. Jaimes. (2022). High Dose Methotrexate-Induced Acute Kidney Injury: Incidence, Risk Factors, and Recovery. Kidney International Reports. 8(2). 360–364. 10 indexed citations
6.
Latcha, Sheron & Chintan V. Shah. (2022). Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase. Seminars in Nephrology. 42(6). 151342–151342. 1 indexed citations
7.
8.
Shirazian, Shayan, et al.. (2021). Cancer Screening in End-Stage Kidney Disease. Advances in Chronic Kidney Disease. 28(5). 502–508.e1. 5 indexed citations
9.
Sprangers, Ben, Marije E. Hamaker, Siri Rostoft, et al.. (2021). Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situation. The Lancet Healthy Longevity. 2(1). e42–e52. 1 indexed citations
10.
Latcha, Sheron, et al.. (2020). “Please Keep Mom Alive One More Day”—Clashing Directives of a Dying Patient and Her Surrogate. Journal of Pain and Symptom Management. 59(5). 1147–1152. 2 indexed citations
11.
Sprangers, Ben, Ala Abudayyeh, Sheron Latcha, Mark A. Perazella, & Kenar D. Jhaveri. (2020). How to determine kidney function in cancer patients?. European Journal of Cancer. 132. 141–149. 22 indexed citations
12.
Latcha, Sheron, Edgar A. Jaimes, Victoria Gutgarts, & Surya V. Seshan. (2018). Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib. Kidney International Reports. 3(6). 1477–1481. 7 indexed citations
13.
14.
Finelli, Antonio, Nofisat Ismaila, Jeremy C. Durack, et al.. (2017). Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 35(6). 668–680. 228 indexed citations
15.
Flombaum, Carlos D., et al.. (2012). Long term renal toxicity of ifosfamide in adult patients – 5year data. European Journal of Cancer. 48(9). 1326–1331. 26 indexed citations
16.
Latcha, Sheron, Michelle Lubetzky, & Alan M. Weinstein. (2011). Severe hyperosmolarity and hypernatremia in an adipsic young woman. Clinical Nephrology. 76(11). 407–411. 13 indexed citations
17.
Steinherz, Peter G., Neerav Shukla, Rachel Kobos, & Sheron Latcha. (2010). Effect of hemodialysis on the plasma levels of clofarabine. Pediatric Blood & Cancer. 55(1). 196–198. 3 indexed citations
18.
Latcha, Sheron, Robert G. Maki, Gary K. Schwartz, & Carlos D. Flombaum. (2009). Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis. Sarcoma. 2009. 1–5. 6 indexed citations
19.
Latcha, Sheron, Susana Hong, Nora Gibbons, Nina Kohn, & Joseph Mattana. (2008). Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis. Nephrology Dialysis Transplantation. 23(10). 3295–3301. 7 indexed citations
20.
Mossey, Robert T., et al.. (2004). Recurrent membranous nephropathy and leiomyosarcoma in the renal allograft of a lupus patient. Journal of Nephrology. 17(1). 134–138.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fulya Öz Puyan Breakdown of academic impact, for papers by Kouju Kamata Breakdown of academic impact, for papers by Keith E. Eidman Breakdown of academic impact, for papers by Nathan Susnik Breakdown of academic impact, for papers by Qing Jiang Breakdown of academic impact, for papers by Snehal G. Thakkar Breakdown of academic impact, for papers by Wenyu Zou Breakdown of academic impact, for papers by Jingyuan Wang Breakdown of academic impact, for papers by Yi Shao Breakdown of academic impact, for papers by Taro Kubo
Rankless by CCL
2026